Table III.
Treatment selections and survival of pancreatic cancer patients.
| Parameter | No. | Median survival (months; 95% CI) | P-value | Hazard ratio (95% CI) |
|---|---|---|---|---|
| Supportive or no therapy | 67 | 1.3 (1.0–3.0) | ||
| Surgery | 140 | 11.0 (7.8–13.5) | 0.000 | 0.39 (0.28–0.55) |
| Chemotherapy | 115 | 7.3 (6.0–9.3) | 0.000 | 0.48 (0.35–0.68) |
| Endoscopic retrograde biliary drainage | 17 | 3.5 (2.2–8.8) | 0.031 | 0.48 (0.24–0.94) |
| Transcatheter arterial infusion chemotherapy | 57 | 9.0 (7.3–12.8) | 0.000 | 0.43 (0.29–0.63) |
| Combined therapy | 86 | 11.0 (9.0–14.2) | 0.000 | 0.38 (0.26–0.54) |